Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




At Least Twenty Genes Regulate Cellular Cholesterol Metabolism

By LabMedica International staff writers
Posted on 16 Jul 2009
Print article
Maintaining the proper level of cholesterol is critical to avoiding vascular lipid deposits that are the prelude to heart disease. To manage this task cells utilize a panel of at least 20 enzymes.

To study how cells maintain their cholesterol balance at the molecular level investigators at the University of Heidelberg (Germany) first used genome-wide gene-expression profiling of sterol-depleted cells and systematic literature queries to identify candidate genes. To further refine the list of candidate genes they developed two microscopic assays that allowed them to observe how blocking individual genes with siRNA (small interfering RNA) affected cholesterol metabolism. One assay used the cholesterol-binding dye Filipin to visualize cellular cholesterol levels, while the other employed fluorescence-labeled LDL (low density lipoprotein) to show cellular internalization.

Results published in the July 8, 2009, issue of the journal Cell Metabolism revealed that 20 genes acted as functional regulators of cellular cholesterol homeostasis. Of these, the TMEM97 gene was identified as an SREBP (sterol regulatory element binding protein) target gene that under sterol-depleted conditions localized to lysosomal compartments and bound to the LDL cholesterol transport-regulating protein Niemann-Pick C1 (NPC1).

SREBPs are transcription factors that bind to the sterol regulatory element DNA sequence TCACNCCAC. When not activated, SREBPs are attached to the nuclear envelope and endoplasmic reticulum membranes. In cells with low levels of sterols, SREBPs are cleaved to a water-soluble N-terminal domain that migrates to the nucleus. These activated SREBPs then bind to specific sterol regulatory element DNA sequences and up regulate the synthesis of enzymes involved in sterol biosynthesis. Sterols in turn inhibit the cleavage of SREBPs, and therefore synthesis of additional sterols is reduced through a negative feed back loop.

"High cholesterol in the blood is considered to be responsible for excess cardiovascular morbidity and mortality," said Dr. Heiko Runz, professor of human genetics at the University of Heidelberg. "Blood cholesterol levels are controlled by cholesterol in cells. Therefore, some of the genes identified by us as regulators of cellular cholesterol in future studies might turn out to be disease genes that contribute to hypercholesterolemia in some cases. Moreover, the strategy we used could open a new avenue to identify risk factors for cardiovascular disease."

Related Links:

University of Heidelberg



Gold Member
Veterinary Hematology Analyzer
Exigo H400
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Silver Member
ACTH Assay
ACTH ELISA
New
Toxoplasma Gondii Immunoassay
Toxo IgM AccuBind ELISA Kit

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.